Roald Tolkien
Cancer, particularly pulmonary cancer or lung cancer, remains one of the leading causes of death globally. Over the years, significant advancements have been made in understanding the molecular mechanisms underlying cancer growth and progression. Traditional treatment options like surgery, chemotherapy and radiation therapy have played pivotal roles in managing pulmonary cancer, but they often come with substantial side effects and limited success rates, especially in advanced stages. In recent years, immunotherapy has emerged as a promising and revolutionary approach in the management of pulmonary cancer. This article delves into the role of immunotherapy in pulmonary cancer treatment, its mechanisms, challenges and future prospects.
இந்தக் கட்டுரையைப் பகிரவும்